Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects

Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects

The addition of ultra-low-dose naloxone to patient-controlled analgesia (PCA) with morphine reduces opioid-related side effects. Nalbuphine, a mixed opioid agonist–antagonist, may be able to attenuate opioid-related side effects. The goal of the present study was to investigate the effect of combine...

Full description

Bibliographic Details
Main Authors: Yu-Chang Yeh, Tzu-Fu Lin, Hung-Chi Chang, Wing-Sum Chan, Yong-Ping Wang, Chen-Jung Lin, Wei-Zen Sun
Format: Article
Language:English
Published: Elsevier 2009-07-01
Series:Journal of the Formosan Medical Association
Subjects:
adverse effects
morphine
nalbuphine
opioids
patient-controlled analgesia
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664609603727

Internet

http://www.sciencedirect.com/science/article/pii/S0929664609603727

Similar Items